REGN vs TM · P/E 14, rev $14.34B vs P/E 9.7, rev $234.60B
Regeneron Pharmaceuticals Inc (REGN) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the REGN and TM stock pages for the full models.
Not investment advice.